Neoadjuvant chemotherapy for high-grade serous ovarian cancer: radiologic-pathologic correlation of response assessment and predictors of progression.
Molly E RoselandTianwen MaKimberly L ShampainErica B SteinAshish P WasnikNicole E CurciAndrew P SciallisShitanshu UppalTimothy D JohnsonKatherine E MaturenPublished in: Abdominal radiology (New York) (2024)
HGSC response to neoadjuvant therapy by CT S-PCI did not predict pathologic CRS score, optimal debulking, or progression, revealing discordance between imaging, pathologic, biochemical, and surgical assessments of tumor response.
Keyphrases
- neoadjuvant chemotherapy
- high grade
- locally advanced
- lymph node
- rectal cancer
- sentinel lymph node
- low grade
- squamous cell carcinoma
- radiation therapy
- high resolution
- acute myocardial infarction
- acute coronary syndrome
- coronary artery disease
- percutaneous coronary intervention
- contrast enhanced
- magnetic resonance
- stem cells
- image quality
- positron emission tomography
- mesenchymal stem cells
- early stage
- st segment elevation myocardial infarction
- cell therapy